Holley-Shanks RR - Search Results

1

Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies.

Yee KW, Hagey A, Verstovsek S, Cortes J, Garcia-Manero G, O'Brien SM, Faderl S, Thomas D, Wierda W, Kornblau S, Ferrajoli A, Albitar M, McKeegan E, Grimm DR, Mueller T, Holley-Shanks RR, Sahelijo L, Gordon GB, Kantarjian HM, Giles FJ. Yee KW, et al. Among authors: holley shanks rr. Clin Cancer Res. 2005 Sep 15;11(18):6615-24. doi: 10.1158/1078-0432.CCR-05-0650. Clin Cancer Res. 2005. PMID: 16166440 Clinical Trial.

2

ABT-888, an orally active poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models.

Donawho CK, Luo Y, Luo Y, Penning TD, Bauch JL, Bouska JJ, Bontcheva-Diaz VD, Cox BF, DeWeese TL, Dillehay LE, Ferguson DC, Ghoreishi-Haack NS, Grimm DR, Guan R, Han EK, Holley-Shanks RR, Hristov B, Idler KB, Jarvis K, Johnson EF, Kleinberg LR, Klinghofer V, Lasko LM, Liu X, Marsh KC, McGonigal TP, Meulbroek JA, Olson AM, Palma JP, Rodriguez LE, Shi Y, Stavropoulos JA, Tsurutani AC, Zhu GD, Rosenberg SH, Giranda VL, Frost DJ. Donawho CK, et al. Among authors: holley shanks rr. Clin Cancer Res. 2007 May 1;13(9):2728-37. doi: 10.1158/1078-0432.CCR-06-3039. Clin Cancer Res. 2007. PMID: 17473206

3

Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics.

Katz DA, Carr R, Grimm DR, Xiong H, Holley-Shanks R, Mueller T, Leake B, Wang Q, Han L, Wang PG, Edeki T, Sahelijo L, Doan T, Allen A, Spear BB, Kim RB. Katz DA, et al. Clin Pharmacol Ther. 2006 Mar;79(3):186-96. doi: 10.1016/j.clpt.2005.11.003. Epub 2006 Feb 17. Clin Pharmacol Ther. 2006. PMID: 16513443

4

Impact of CYP2D6 intermediate metabolizer alleles on single-dose desipramine pharmacokinetics.

Furman KD, Grimm DR, Mueller T, Holley-Shanks RR, Bertz RJ, Williams LA, Spear BB, Katz DA. Furman KD, et al. Among authors: holley shanks rr. Pharmacogenetics. 2004 May;14(5):279-84. doi: 10.1097/00008571-200405000-00002. Pharmacogenetics. 2004. PMID: 15115913

5

Mapping of microsatellite markers developed from a flow-sorted swine chromosome 6 library.

Grimm DR, Goldman T, Holley-Shanks R, Buoen L, Mendiola J, Schook LB, Louis C, Rohrer GA, Lunney JK. Grimm DR, et al. Mamm Genome. 1997 Mar;8(3):193-9. doi: 10.1007/s003359900388. Mamm Genome. 1997. PMID: 9069120

6

Pharmacological and molecular characterization of a dorsal root ganglion cell line expressing cannabinoid CB(1) and CB(2) receptors.

Fan Y, Hooker BA, Garrison TR, El-Kouhen OF, Idler KB, Holley-Shanks RR, Meyer MD, Yao BB. Fan Y, et al. Among authors: holley shanks rr. Eur J Pharmacol. 2011 Jun 1;659(2-3):161-8. doi: 10.1016/j.ejphar.2011.03.020. Epub 2011 Mar 31. Eur J Pharmacol. 2011. PMID: 21458448

7

Association of dopamine-related genetic loci to dopamine D3 receptor antagonist ABT-925 clinical response.

Bhathena A, Wang Y, Kraft JB, Idler KB, Abel SJ, Holley-Shanks RR, Robieson WZ, Spear B, Redden L, Katz DA. Bhathena A, et al. Among authors: holley shanks rr. Transl Psychiatry. 2013 Apr 9;3(4):e245. doi: 10.1038/tp.2013.22. Transl Psychiatry. 2013. PMID: 23571810 Free PMC article. Clinical Trial.

8

Construction of internal cDNA competitors for measuring IL-10 and IL-12 cytokine gene expression in swine.

Mansfield LS, Urban JF, Holley-Shanks RR, Murtaugh MP, Zarlenga DS, Foss D, Canals A, Gause W, Lunney JK. Mansfield LS, et al. Among authors: holley shanks rr. Vet Immunol Immunopathol. 1998 Sep 16;65(1):63-74. doi: 10.1016/s0165-2427(98)00106-8. Vet Immunol Immunopathol. 1998. PMID: 9802577

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters